Crinetics Pharmaceuticals (CRNX) Stock Price
$44.93 0%
to add to portfolio
AI Score
-
Alternative
10 -
Fundamental
7 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Crinetics Pharmaceuticals, AI stock picks, stock alerts and much more.
CRNX AI Stock Analysis
AI stock analysis for CRNX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Crinetics Pharmaceuticals (CRNX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Crinetics Pharmaceuticals (CRNX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Crinetics Pharmaceuticals (CRNX), currently trading at $44.93, will... Sign up to access price prediction.
About CRNX
-
Crinetics Pharmaceuticals, Inc.
-
Symbol
CRNX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
4.2B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$20.36 2.2% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.57 3% |
2 |
 |
Moderna MRNA |
$26.83 2.5% |
4 |
 |
Anavex Life Sciences AVXL |
$9.27 2.6% |
5 |
 |
BridgeBio Pharma BBIO |
$55.49 1.3% |
6 |
News
CRNX Alternative Data
Web Traffic
Crinetics Pharmaceuticals receives an estimated 21912 monthly visitors to crinetics.com, which is up by 41.1% over the last month.
-
Web Traffic
21912
-
Change from Previous Month
41.1%
-
3 Month Change
91.5%
-
YoY Change
91.5%
Twitter Followers
Crinetics Pharmaceuticals has 1,055 Twitter Followers on its main Twitter (also known as X) account, which is up by 5.3% over the last month.
-
Twitter Followers
1055
-
Daily Change
0%
-
1 Month Change
5.3%
-
3 Month Change
8.9%
-
YoY Change
8.9%
Facebook Engagement
Crinetics Pharmaceuticals has engaged 50 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
50
-
Daily Change
0%
-
1 Month Change
400%
-
3 Month Change
2400%
-
YoY Change
2400%
LinkedIn Followers
40,336 are following Crinetics Pharmaceuticals on LinkedIn, up by 5.1% over the last month.
-
LinkedIn Followers
40336
-
Daily Change
0.1%
-
1 Month Change
5.1%
-
3 Month Change
14.4%
-
YoY Change
14.4%
Job Postings
Crinetics Pharmaceuticals has an estimated 30 open job postings, which is down -6.3% over the last month.
-
Job Postings
30
-
Daily Change
0%
-
1 Month Change
6.3%
-
3 Month Change
44.4%
-
YoY Change
44.4%
LinkedIn Employees
According to LinkedIn, Crinetics Pharmaceuticals has 553 employees, up by 4.1% over the last month.
-
LinkedIn Employees
553
-
Daily Change
0%
-
1 Month Change
4.1%
-
3 Month Change
15%
-
YoY Change
15%
Reddit Mentions
Crinetics Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Crinetics Pharmaceuticals has 167 Instagram Followers on its main Instagram account, up by 5.7% over the last month.
-
Instagram Followers
167
-
Daily Change
0.6%
-
1 Month Change
5.7%
-
3 Month Change
7.1%
-
YoY Change
7.1%
Business Outlook
According to employee reviews, the business outlook among employees at Crinetics Pharmaceuticals is 90 out of 100 (very bullish).
-
Business Outlook
90
-
Change from Previous Month
1.1%
-
3 Month Change
1.1%
-
YoY Change
1.1%
News Mentions
Crinetics Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CRNX Financials
CRNX Key Metrics
-
Total Revenue
$0
-
Net Income
-$80.6M
-
Earnings per Share
-$0.88
-
Free cash flow
-$65.7M
-
EBITDA
-$94M
-
EBITDA Ratio
0
-
Total Assets
$1.4B
CRNX 2-year Revenue & Income
CRNX 2-year Free Cash Flow
CRNX Technicals
CRNX SMA
CRNX RSI
FAQ
What's the current price of Crinetics Pharmaceuticals (CRNX) Stock?
The price of an Crinetics Pharmaceuticals (CRNX) share is $44.93.
What's the market cap of Crinetics Pharmaceuticals?
The current market cap of Crinetics Pharmaceuticals is 4.2B.
What are some stocks similar to Crinetics Pharmaceuticals (CRNX) that investors often compare it to?
Crinetics Pharmaceuticals (CRNX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Crinetics Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Crinetics Pharmaceuticals' stock price to be around $51.62 in 2026. Starting from the current price of $44.93, this represents a 14.9% change in price, indicating a bullish outlook for the stock.
How to buy Crinetics Pharmaceuticals (CRNX) Stock?
Crinetics Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Crinetics Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.